ATYPICAL FRACTURE FEMUR FOLLOWING LONG TERM PREDNISOLONE AND ALENDRONATE MEDICATION: A CASE REPORT
Matrix Science Pharma · 2018
DOI: 10.26480/msp.02.2018.04.05 ↗Kurz gefasst
Fallbericht in der Zeitschrift Matrix Science Pharma, 2018. Verfasst von Reddy und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
In recent years several reports of atypical fracture (AFF) of the femur occurring in postmenopausal osteoporosis patients, on long term bisphosphonate therapy, are noted in the literature.In comparison only, few cases of these type of fractures occurring in patients, on concomitant glucocorticoid and bisphosphonate medication, are reported.Here, we are reporting one such case belonging to this sub-group.
Zitieren
APA
Reddy, B.N., & M, A. A. (2018). ATYPICAL FRACTURE FEMUR FOLLOWING LONG TERM PREDNISOLONE AND ALENDRONATE MEDICATION: A CASE REPORT. Matrix Science Pharma. https://doi.org/10.26480/msp.02.2018.04.05
Vancouver
Reddy, B.N., M AA. ATYPICAL FRACTURE FEMUR FOLLOWING LONG TERM PREDNISOLONE AND ALENDRONATE MEDICATION: A CASE REPORT. Matrix Science Pharma. 2018. doi:10.26480/msp.02.2018.04.05
BibTeX
@article{Reddy2018,
author = {Reddy and B.N. and M, Abdullah Aqueel},
title = {ATYPICAL FRACTURE FEMUR FOLLOWING LONG TERM PREDNISOLONE AND ALENDRONATE MEDICATION: A CASE REPORT},
journal = {Matrix Science Pharma},
year = {2018},
doi = {10.26480/msp.02.2018.04.05}
}
EUVIMED